DGXQuest Diagnostics

Health care · Medical Labs · NYSE

Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. 10-K, Item 1

Employees: 57,000
Headquarters: Secaucus, NJ
CEO: J. E. Davis
Next results: around Jan 11, 2027

The numbers DGX said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.

Of 3 range targets with a reported result: 2 came in above the last range given, 1 within it, 0 below it.

Target	What the company said	Reported	Result
Diluted EPS Fiscal 2026	Given $9.45 to $9.65 release 2026-02-10 Raised $9.58 to $9.78 release 2026-04-21 Raised $9.97 to $10.17 release 2026-07-23 Raised $10.21 to $10.31 release 2026-10-22	–	Not reported yet
The company's words Full year 2026 reported diluted EPS expected to be between $9.45 and $9.65; and adjusted diluted EPS expected to be between $10.50 and $10.70 release 2026-02-10 Full year 2026 reported diluted EPS now expected to be between $9.58 and $9.78; and adjusted diluted EPS is expected to be between $10.63 and $10.83 release 2026-04-21 Full year 2026 reported diluted EPS now expected to be between $9.97 and $10.17; and adjusted diluted EPS expected to be between $11.05 and $11.25 release 2026-07-23 Full year 2026 reported diluted EPS now expected to be between $10.21 and $10.31; and adjusted diluted EPS expected to be between $11.25 and $11.35 release 2026-10-22
Diluted EPS (company-defined) Fiscal 2026	Given $10.50 to $10.70 release 2026-02-10 Raised $10.63 to $10.83 release 2026-04-21 Raised $11.05 to $11.25 release 2026-07-23 Raised $11.25 to $11.35 release 2026-10-22	–	No standard number
The company's words Provides Guidance for Full Year 2026; … Full year 2026 reported diluted EPS expected to be between $9.45 and $9.65; and adjusted diluted EPS expected to be between $10.50 and $10.70 release 2026-02-10 Raises Revenue and EPS Guidance for Full Year 2026 … Full year 2026 reported diluted EPS now expected to be between $9.58 and $9.78; and adjusted diluted EPS is expected to be between $10.63 and $10.83 release 2026-04-21 Raises Revenue and EPS Guidance for Full Year 2026 … Full year 2026 reported diluted EPS now expected to be between $9.97 and $10.17; and adjusted diluted EPS expected to be between $11.05 and $11.25 release 2026-07-23 Raises Revenue and EPS Guidance for Full Year 2026 … Full year 2026 reported diluted EPS now expected to be between $10.21 and $10.31; and adjusted diluted EPS expected to be between $11.25 and $11.35 release 2026-10-22
Revenue Fiscal 2026	Given $11.70B to $11.82B release 2026-02-10 Raised $11.95B to $12.05B release 2026-07-23 Raised $12.06B to $12.11B release 2026-10-22	–	Not reported yet
The company's words Full year 2026 revenues expected to be between $11.70 billion and $11.82 billion release 2026-02-10 Full year 2026 revenues now expected to be between $11.95 billion and $12.05 billion release 2026-07-23 Full year 2026 revenues now expected to be between $12.065 billion and $12.105 billion release 2026-10-22
Diluted EPS Fiscal 2025 (ended 2025-12-31)	Given $8.34 to $8.59 release 2025-01-30 Raised $8.62 to $8.87 release 2025-04-22 Lowered $8.60 to $8.80 release 2025-07-22 Lowered $8.58 to $8.66 release 2025-10-21	$8.75 10-K filed 2026-02-26	Above the range
The company's words Full year 2025 reported diluted EPS expected to be between $8.34 and $8.59; and adjusted diluted EPS expected to be between $9.55 and $9.80 release 2025-01-30 Full year 2025 reported diluted EPS now expected to be between $8.62 and $8.87; and adjusted diluted EPS is expected to remain between $9.55 and $9.80 release 2025-04-22 Full year 2025 reported diluted EPS now expected to be between $8.60 and $8.80; and adjusted diluted EPS is expected to be between $9.63 and $9.83 release 2025-07-22 Full year 2025 reported diluted EPS now expected to be between $8.58 and $8.66; and adjusted diluted EPS is expected to be between $9.76 and $9.84 release 2025-10-21
Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-31)	Given $9.55 to $9.80 release 2025-01-30 Kept $9.55 to $9.80 release 2025-04-22 Raised $9.63 to $9.83 release 2025-07-22 Raised $9.76 to $9.84 release 2025-10-21	–	No standard number
The company's words Provides Guidance for Full Year 2025; … Full year 2025 reported diluted EPS expected to be between $8.34 and $8.59; and adjusted diluted EPS expected to be between $9.55 and $9.80 release 2025-01-30 Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 … Full year 2025 reported diluted EPS now expected to be between $8.62 and $8.87; and adjusted diluted EPS is expected to remain between $9.55 and $9.80 release 2025-04-22 Raises Guidance for Full Year 2025 … Full year 2025 reported diluted EPS now expected to be between $8.60 and $8.80; and adjusted diluted EPS is expected to be between $9.63 and $9.83 release 2025-07-22 Raises Guidance for Full Year 2025 … Full year 2025 reported diluted EPS now expected to be between $8.58 and $8.66; and adjusted diluted EPS is expected to be between $9.76 and $9.84 release 2025-10-21
Diluted EPS Fiscal 2024 (ended 2024-12-31)	Given $7.69 to $7.99 release 2024-02-01 Lowered $7.57 to $7.82 release 2024-04-23 Lowered $7.57 to $7.77 release 2024-07-23 Lowered $7.60 to $7.70 release 2024-10-22	$7.69 10-K filed 2025-02-20	Within the range
The company's words Full year 2024 reported diluted EPS expected to be between $7.69 and $7.99; and adjusted diluted EPS expected to be between $8.60 and $8.90 release 2024-02-01 Raises Guidance for Full Year 2024 … Full year 2024 revenues now expected to be between $9.40 billion and $9.48 billion; reported diluted EPS now expected to be between $7.57 and $7.82; and adjusted diluted EPS expected to be between $8.72 and $8.97 release 2024-04-23 Raises Guidance for Full Year 2024 … Full year 2024 revenues now expected to be between $9.50 billion and $9.58 billion; reported diluted EPS now expected to be between $7.57 and $7.77; and adjusted diluted EPS expected to be between $8.80 and $9.00 release 2024-07-23 Updates Guidance for Full Year 2024 … Full year 2024 revenues now expected to be between $9.80 billion and $9.85 billion; reported diluted EPS now expected to be between $7.60 and $7.70; and adjusted diluted EPS expected to be between $8.85 and $8.95 release 2024-10-22
Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-31)	Given $8.60 to $8.90 release 2024-02-01 Raised $8.72 to $8.97 release 2024-04-23 Raised $8.80 to $9.00 release 2024-07-23 Narrowed $8.85 to $8.95 release 2024-10-22	–	No standard number
The company's words Provides Guidance for Full Year 2024; … Full year 2024 reported diluted EPS expected to be between $7.69 and $7.99; and adjusted diluted EPS expected to be between $8.60 and $8.90 release 2024-02-01 Raises Guidance for Full Year 2024 … Full year 2024 revenues now expected to be between $9.40 billion and $9.48 billion; reported diluted EPS now expected to be between $7.57 and $7.82; and adjusted diluted EPS expected to be between $8.72 and $8.97 release 2024-04-23 Raises Guidance for Full Year 2024 … Full year 2024 revenues now expected to be between $9.50 billion and $9.58 billion; reported diluted EPS now expected to be between $7.57 and $7.77; and adjusted diluted EPS expected to be between $8.80 and $9.00 release 2024-07-23 Updates Guidance for Full Year 2024 … Full year 2024 revenues now expected to be between $9.80 billion and $9.85 billion; reported diluted EPS now expected to be between $7.60 and $7.70; and adjusted diluted EPS expected to be between $8.85 and $8.95 release 2024-10-22
Revenue Fiscal 2024 (ended 2024-12-31)	Given $9.40B to $9.48B release 2024-04-23 Raised $9.50B to $9.58B release 2024-07-23 Raised $9.80B to $9.85B release 2024-10-22	$9.87B 10-K filed 2025-02-20	Above the range
The company's words Full year 2024 revenues now expected to be between $9.40 billion and $9.48 billion; reported diluted EPS now expected to be between $7.57 and $7.82; and adjusted diluted EPS expected to be between $8.72 and $8.97 release 2024-04-23 Full year 2024 revenues now expected to be between $9.50 billion and $9.58 billion; reported diluted EPS now expected to be between $7.57 and $7.77; and adjusted diluted EPS expected to be between $8.80 and $9.00 release 2024-07-23 Full year 2024 revenues now expected to be between $9.80 billion and $9.85 billion; reported diluted EPS now expected to be between $7.60 and $7.70; and adjusted diluted EPS expected to be between $8.85 and $8.95 release 2024-10-22

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2024-02-01), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Work on DGX in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/DGX/export.csv") into a cell.